Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05956912 |
Recruitment Status :
Recruiting
First Posted : July 24, 2023
Last Update Posted : July 24, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background: Cardiac rehabilitation (CR) services aim to improve heart disease patients' health and quality of life and reduce the risk of further cardiac events. Depression and anxiety are common among CR patients, and current psychological treatments for cardiac patients have minor effects. However, the NIHR-funded PATHWAY trial found that group Metacognitive Therapy (MCT) was associated with improvements in anxiety and depression when added to CR and was more effective than usual CR alone. Group MCT was also associated with preventing anxiety and depression. The next steps will establish beacon sites for delivering MCT and pilot-test additions to the national audit of cardiac rehabilitation (NACR) data capture mechanism to include an MCT data field. Such steps will support a quantitative and qualitative evaluation of implementation.
Methods: The investigators aim to address questions concerning the quality of patient data recorded, level of adoption at sites, the characteristics of patients attending MCT, the impact of adding MCT to CR on mental health outcomes, and patient, healthcare staff and commissioner views of barriers/enablers to implementation. The investigators will deliver training in group MCT to CR staff from CR services across England. The investigators will conduct semi-structured qualitative interviews with CR staff trained in group MCT to assess views on the training programme, including successes and barriers to implementation of training and delivery. The investigators will interview 8-10 CR stakeholders to identify any barriers to implementation and how these might be resolved.
Discussion: The study will support development of an NHS roll-out strategy and systematic data collection that can be used to evaluate wide-scale implementation. The study can benefit service users by improving patients' mental health outcomes and CR practitioners' clinical skills. Results will be disseminated via peer-reviewed journals, national and international conferences and service user/voluntary sector organisations and networks.
Condition or disease |
---|
Anxiety Depression Cardiac Rehabilitation |
Study Type : | Observational [Patient Registry] |
Estimated Enrollment : | 100 participants |
Observational Model: | Other |
Time Perspective: | Prospective |
Target Follow-Up Duration: | 6 Months |
Official Title: | Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons) |
Actual Study Start Date : | September 6, 2022 |
Estimated Primary Completion Date : | August 31, 2023 |
Estimated Study Completion Date : | August 31, 2023 |
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
- Adoption of group MCT [ Time Frame: Within the 6 months that MCT is being delivered in CR services ]
Successful adoption of group MCT at each site is set a-priori. A traffic-light criteria will be used to determine successful adoption.
- Green - achieved all of the following: a) Delivered two 6-session group MCT courses (b) at least three patients per group, and (c) a combined total of at least 60% attending four or more sessions.
- Amber - achieved one of the three criteria given above.
- Red - achieved none of the criteria.
A Green rating indicates that a site has fully met the criteria for successful adoption. Red indicates a failure to meet the requirements. Amber is partial adoption, where amendments to procedures and protocols might lead to successful adoption. At Amber sites, specific qualitative work will be undertaken to understand the reasons for not meeting criteria more fully and to help develop strategies to ameliorate this. An overall assessment will be made considering the traffic-light ratings of all six beacon sites.
- Dartmouth Coop [ Time Frame: Initial Cardiac Rehabilitation Assessment (Baseline) & Within 6 months of attending cardiac rehabilitation (Discharge) ]The COOP will be captured through the National Audit for Cardiac Rehabilitation. It is a self-report measure designed to evaluate the functional abilities of medical patients. It consists of nine items covering various areas such as physical function, daily activities, pain, social activities, social support, emotions, overall health, changes in health, and quality of life. Each chart includes text and illustrations to assist the user in responding. The responses are graded on an ordinal scale of 1 to 5, with one being the best score.
- Semi-structured interviews will explore the views and opinions of group-MCT in CR (CR staff trained in group-MCT) [ Time Frame: 1 month prior to training in MCT ]To understand what CR staff views of training in group MCT are with a view to understanding enablers and barriers. To understand the consequences, both expected and unexpected, of implementing group-MCT, for example on existing CR services, staffing needs, administration and resource requirements.
- Semi-structured interviews will explore the views and opinions of group-MCT in CR (CR staff trained in group-MCT) [ Time Frame: Within 1 month of delivering the pilot group of MCT ]To understand what CR staff views of training in group MCT are with a view to understanding enablers and barriers. To understand the consequences, both expected and unexpected, of implementing group-MCT, for example on existing CR services, staffing needs, administration and resource requirements.
- Semi-structured interviews will explore the views and opinions of group-MCT in CR (CR staff trained in group-MCT) [ Time Frame: Upon completion of delivering group-MCT, approximately 5 months after starting the delivery of MCT in CR ]To understand what CR staff views of training in group MCT are with a view to understanding enablers and barriers. To understand the consequences, both expected and unexpected, of implementing group-MCT, for example on existing CR services, staffing needs, administration and resource requirements.
- Semi-structured interviews will explore the views and opinions of group-MCT in CR (CCG and other management stakeholders) [ Time Frame: Through implementation of MCT in CR services, approximately 7 months. ]To understand the acceptability and feasibility of roll-out at commissioner level and what the enablers or barriers are. To understand the consequences, both expected and unexpected, of implementing group-MCT, for example on existing CR services, staffing needs, administration and resource requirements.
- Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Initial Cardiac Rehabilitation Assessment (Baseline) & Within 6 months of attending cardiac rehabilitation (Discharge) ]The HADS will be captured through the National Audit for Cardiac Rehabilitation. It is a 14-item self-report questionnaire that measures symptoms of anxiety (7 items) and depression (7 items). Items are rated using a 4-point (0-3) scale, with higher scores indicating elevated distress. Scores for each subscale range from 0 to 21 and can be categorised as normal (0-7), mild (8-10), moderate (11-14), or severe (15-21).
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Cardiac rehabilitation staff trained in delivering Group-MCT, wider cardiac rehabilitation staff and managers, and healthcare professionals from local clinical commissioning groups.
All CR patients attending cardiac rehabilitation.
Qualitative Inclusion Criteria:
All CR staff must meet the following inclusion criteria to be eligible:
- Be a healthcare professional working with cardiac rehabilitation services being trained to deliver group-MCT
- Be a healthcare professional working with cardiac rehabilitation or be a professional working at the commissioner level
- Minimum of 18 years old
- Competent level of English Language skills (able to read, understand and complete interviews in English).
Exclusion Criteria:
- Below 18 years of age
- Not a healthcare professional or professional working at the commissioner level
- Does not have a competent level of English language skills
Audit inclusion criteria:
All patients attending CR who meet the NICE recommendations for acute coronary syndrome (NG185) and heart failure (NG106) will be offered group MCT as part of routine CR.
![](/ct2/html/images/NIH_NLM_ABRV_BLK_4.png)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05956912
Contact: Adrian Wells, PhD | 01612765399 | adrian.wells@manchester.ac.uk | |
Contact: Lora Capobianco, PhD | 01610046664 | lora.capobianco@gmmh.nhs.uk |
United Kingdom | |
Manchester University NHS Foundation Trust | Recruiting |
Manchester, United Kingdom, M13 9WL | |
Contact: Lora Capobianco, PhD Lora.capobianco@gmmh.nhs.uk |
Principal Investigator: | Adrian Wells, PhD | University of Manchester |
Responsible Party: | Adrian Wells, Professor of Clinical and Experimental Psychopathology, University of Manchester |
ClinicalTrials.gov Identifier: | NCT05956912 |
Other Study ID Numbers: |
IRAS ID: 313677 29567 ( Other Grant/Funding Number: NIHR ) |
First Posted: | July 24, 2023 Key Record Dates |
Last Update Posted: | July 24, 2023 |
Last Verified: | July 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Depression Behavioral Symptoms |